Correlation Between Novartis and Swisscom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novartis and Swisscom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Swisscom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG and Swisscom AG, you can compare the effects of market volatilities on Novartis and Swisscom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Swisscom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Swisscom.

Diversification Opportunities for Novartis and Swisscom

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Novartis and Swisscom is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG and Swisscom AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swisscom AG and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG are associated (or correlated) with Swisscom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swisscom AG has no effect on the direction of Novartis i.e., Novartis and Swisscom go up and down completely randomly.

Pair Corralation between Novartis and Swisscom

Assuming the 90 days trading horizon Novartis AG is expected to generate 1.44 times more return on investment than Swisscom. However, Novartis is 1.44 times more volatile than Swisscom AG. It trades about 0.06 of its potential returns per unit of risk. Swisscom AG is currently generating about 0.0 per unit of risk. If you would invest  9,327  in Novartis AG on November 29, 2024 and sell it today you would earn a total of  376.00  from holding Novartis AG or generate 4.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Novartis AG  vs.  Swisscom AG

 Performance 
       Timeline  
Novartis AG 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Novartis AG are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Novartis is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Swisscom AG 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Swisscom AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Swisscom is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Novartis and Swisscom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novartis and Swisscom

The main advantage of trading using opposite Novartis and Swisscom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Swisscom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swisscom will offset losses from the drop in Swisscom's long position.
The idea behind Novartis AG and Swisscom AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device